Filter
11350
Filtered Results: 11350
Text search:
REVIVE
Featured
Recommendations
931
New Publications
2733
Language
Document type
No document type
6291
Studies & Reports
2006
Guidelines
1487
Manuals
577
Strategic & Response Plan
353
Fact sheets
248
Training Material
209
Situation Updates
71
Resource Platforms
43
Infographics
29
Brochures
22
Online Courses
12
Dashboards/Maps
1
App
1
Countries / Regions
Global
440
India
408
Kenya
300
Ethiopia
223
South Africa
212
Uganda
203
Sierra Leone
193
Nigeria
192
Western and Central Europe
191
Nepal
184
Myanmar / Burma
168
Liberia
167
Africa
165
Malawi
161
Latin America and the Carribbean
148
Rwanda
145
Zambia
145
Congo, Democratic Republic of
134
Bangladesh
131
Tanzania
130
Ghana
122
Senegal
117
Syria
115
Ukraine
111
Indonesia
111
Russia
105
Brazil
95
Eastern Europe
86
Burkina Faso
76
Philippines
76
Haiti
76
Germany
74
Namibia
74
Zimbabwe
70
Guinea
64
West and Central Africa
64
South Sudan
64
Lesotho
62
Asia
62
South–East Asia Region
62
Mozambique
61
Cambodia
57
East and Southern Africa
56
Benin
53
Cameroon
53
Middle East and North Africa
52
Yemen
48
Central African Republic
41
Venezuela
39
Botswana
37
Colombia
36
Eastern Europe and Central Asia
34
Pakistan
31
Afghanistan
29
Eswatini/ Swaziland
27
Peru
25
Lebanon
25
Madagascar
25
Paraguay
24
Chile
23
Argentina
23
Mali
23
Jordan
22
Angola
22
Sudan
21
Somalia
20
Thailand
19
USA
18
Western Pacific Region
18
Vietnam
18
China
16
Tajikistan
15
Guinea-Bissau
13
Côte d’Ivoire / Ivory Coast
13
Albania
12
Iraq
12
Laos
11
Burundi
11
Spain
11
Southern Africa
11
Sri Lanka
11
Ecuador
11
Kyrgyzstan
10
Bolivia
10
Moldova
10
Georgia
10
Niger
9
United Kingdom
9
Palestine
9
Mexico
8
Turkey
8
North America
8
Portugal
8
Libya
8
North Macedonia
7
Togo
7
Kazakhstan
7
Canada
7
Papua New Guinea
7
Egypt
7
Bhutan
7
Iran
6
Armenia
6
Chad
6
Italy
5
Hungary
5
France
5
Romania
5
Greece
5
Timor Leste/ East Timor
4
El Salvador
4
Estonia
4
Uzbekistan
4
Malaysia
4
Turkmenistan
4
Jamaica
4
Japan
4
Belarus
4
Poland
4
Honduras
4
Switzerland
3
Serbia
3
Gambia
3
Singapore
3
Morocco
3
Mongolia
3
Dominican Republic
3
Saudi Arabia
3
Belgium
3
Mauritius
3
Bosnia and Herzegovina
3
Fiji
2
Qatar
2
Bulgaria
2
Croatia
2
Ireland
2
Denmark
2
Tunisia
2
Israel
2
Djibouti
2
Slovakia
2
North Korea
1
Australia
1
Congo-Brazzaville
1
Austria
1
Vanuatu
1
Mauritania
1
Cape Verde
1
Lithuania
1
Luxembourg
1
Gabon
1
Uruguay
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
4120
Clinical Guidelines
827
Women & Child Health
623
Public Health
608
Key Resources
470
Capacity Building
242
Pharmacy & Technologies
101
Annual Report MEDBOX
1
Toolboxes
COVID-19
1107
Mental Health
997
HIV
855
TB
605
Disability
458
Planetary Health
415
Caregiver
339
AMR
311
Rapid Response
290
Ebola
275
Conflict
262
NTDs
254
NCDs
247
Refugee
209
Pharmacy
189
Global Health Education
176
Natural Hazards
118
Health Financing Toolbox
99
Zika
77
Polio
63
Cholera
54
Social Ethics
53
Specific Hazards
52
Typhoon
6
Health Financing
3
South Sudan
1
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
Este documento reúne um conjunto de recomendações formuladas pela OMS e pela OPAS para ajudar os profissionais responsáveis pelos programas de controle de vetores nas Américas em nível nacional, subnacional e local a se atualizarem e tomarem decisões baseadas em evidências sobre as medidas d...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Revised and expanded version of the Guidelines
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
Urogenital schistosomiasis is a common neglected tropical disease in many rural communities in African countries, with patches of infection in the Eastern Mediterranean Region. Globally, an estimated 239 million people are currently infected, with burden estimated at more than 3.5 million disability...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
